scholarly journals STUDIES ON EXPERIMENTAL PNEUMONIA

1920 ◽  
Vol 32 (1) ◽  
pp. 1-18 ◽  
Author(s):  
Russell L. Cecil ◽  
Francis G. Blake

1. In experimental Pneumococcus Type I pneumonia in monkeys the intravenous injection of Type I antipneumococcus serum exercises a specific therapeutic effect, frees the blood promptly and permanently from pneumococci, shortens the course of the disease, and greatly moderates its severity. Of five monkeys inoculated intratracheally with lethal doses of Pneumococcus Type I, all developed pneumonia, and all recovered following the administration of Type I antipneumococcus serum, while the controls died. 2. The earlier the serum is administered the shorter and less severe the pneumonia. Frequent injections are also an important factor in obtaining favorable results. When serum treatment is instituted late in the disease, the injections must usually be continued over a longer period of time in order to achieve success. 3. Normal horse serum exerts no beneficial effect whatever in experimental Pneumococcus Type I pneumonia.

1935 ◽  
Vol 62 (2) ◽  
pp. 281-287 ◽  
Author(s):  
L. A. Barnes ◽  
Eleanor C. Wight

An encapsulated strain of Escherichia coli has been isolated which is hemolytic, pathogenic for mice, and which has served to illustrate further evidence of heterogenetic specificity. The relationship appears to be limited to the serological reactions between the colon organism and Type I antipneumococcic horse serum. Type I antipneumococcic rabbit serum failed to agglutinate the organism and no reactions occurred with Types II and III antipneumococcic horse serums, normal horse serum, and a variety of other immune horse serums. Serum from rabbits immunized with the colon bacillus agglutinated the homologous organism and precipitated its soluble substance, but failed to cause agglutination of Type I pneumococci or to precipitate Type I pneumococcic polysaccharide. The evidence indicates a connection somewhat analogous to that between Type II pneumococcus and Type B Friedländer's bacillus.


1928 ◽  
Vol 48 (1) ◽  
pp. 83-104 ◽  
Author(s):  
Alvan L. Barach ◽  

1. The antigenic function of a pneumococcus vaccine made from the intact cell was compared with that derived fron a watery extract of the cell free from formed elements. In each instance, the immunity produced was dependent upon type-specific protective substance and not upon the elaboration of the common protein antibody. 2. The vaccine made from the intact cell resulted in both active and passive immunity which began on the 3rd day, increased markedly to the 5th, and remained approximately stationery to the 7th day. In the case of the Berkefeld filtrate of the shaken bacteria and the filtrate of the broth culture, the immunity began on the 4th day, increased to the 5th, and remained approximately stationery to the 7th day. The immunity produced by Pneumococcus Type I vaccine is greater than that produced by Type II. On the 3rd day, mice vaccinated with Type I vaccine resisted 100,000 minimal lethal doses, whereas mice immunized with Type II resisted 10,000 minimal lethal doses. On the 5th day, a larger percentage of mice survived these doses than on the 3rd day. 3. Certain factors related to the preparation and dosage of the vaccine are discussed. 4. As far as the time interval and the degree of immunity produced are concerned, these results suggest the possibility of employing pneumococcus vaccine in suitable doses in the treatment of lobar pneumonia. That an earlier activity of the immunity mechanism could actually be initiated in a patient with lobar pneumonia has still to be demonstrated.


1937 ◽  
Vol 66 (2) ◽  
pp. 191-205 ◽  
Author(s):  
Walther F. Goebel ◽  
Rollin D. Hotchkiss

1. Azoprotein antigens containing glucuronic and galacturonic acids give rise in rabbits to specific antibodies. The immune sera show no serological crossing with antigens containing glucose or galactose. 2. The galacturonic acid antigen reacts in antipneumococcus horse serum Type I in high dilutions. 3. Azoprotein antigens containing galacturonic acid, benzene sulfonic and carboxylic acids precipitate in antipneumococcus horse sera of various types but not in normal horse serum. The mechanism underlying these cross reactions is discussed.


1942 ◽  
Vol 75 (1) ◽  
pp. 77-92 ◽  
Author(s):  
Edward C. Curnen ◽  
Colin M. MacLeod

1. Sulfapyridine, administered to rabbits during the period of developing immunity after a single intravenous injection of heat-killed Pneumococcus Type I, exerted no influence upon the immune response. 2. Active immunity as indicated by increased resistance to homologous intradermal infection was present 48 hours after the immunizing injection and 2 days before circulating type specific antibodies were detectable. 3. Of the serological techniques employed for the detection of circulating antibody the mouse protective test yielded the highest percentage of positive results followed in order by tests for type specific agglutinins and precipitins, the latter being least satisfactory for the detection of small amounts of antibody.


1938 ◽  
Vol 67 (4) ◽  
pp. 619-641 ◽  
Author(s):  
Rose G. Miller

1. Inflammation retards the absorption of horse serum globulin and crystalline egg albumin from the peritoneal cavity and subcutaneous tissue, but retardation of the absorption of crystalline egg albumin is less than that of globulin, which is less diffusible. 2. Inflammation retards the absorption of the specific polysaccharide of pneumococcus Type I from the peritoneal cavity; inflammation may accelerate, but does not hinder, the absorption of glucose from the peritoneal cavity. 3. Inflammation retards the spread of trypan blue in the skin, but accelerates absorption from the skin of the more diffusible dye, brom phenol blue. 4. Phenol red is excreted in the urine with equal rapidity after injection into normal and into inflamed subcutaneous tissue or into normal and into inflamed peritoneal cavities. Direct extractions of phenol red from inflamed subcutaneous sites indicate that inflammation accelerates the absorption of the dye from these areas. 5. Inflammation retards the absorption of the indiffusible proteins, carbohydrates and dyes; it tends to accelerate the absorption of the diffusible carbohydrates and dyes.


1919 ◽  
Vol 29 (6) ◽  
pp. 597-603 ◽  
Author(s):  
Harold L. Amoss ◽  
Frederick Eberson

Agglutinins for the meningococcus were not found in the spinal fluid of normal monkeys which had received antimeningococcic serum intravenously. The intraspinal injection of isotonic salt solution, normal horse serum, or a culture of living meningococci allows agglutinins for the meningococcus to pass from the blood to the spinal fluid of the passively immunized monkey; and the rate of the passage is affected by the severity of the inflammation induced in the meninges. The rates of elimination from the blood and spinal canal of meningococcic antibodies, as shown by the agglutination reaction, were compared in monkeys treated with immune serum (a) intraspinally, (b) intravenously, and (c) intraspinally and intravenously in combination. (a) When immune serum is given intraspinally the agglutinins are very much diminished after 8 hours and practically disappear at 12 hours. They appear in the blood at the 4th hour after injection and quickly diminish. (b) After intravenous injection of immune serum, when the meninges are inflamed, agglutinins appear in the spinal fluid in small amounts in about 12 hours and increase to the 25th hour. More than one-half of the agglutinins disappear from the blood within 8 hours and remain in low concentration at 25 hours. (c) After combined intraspinal and intravenous injection the agglutinins remain in higher concentration in the spinal fluid and for a longer time than by method (a) or (b). The curve descends after 12 hours, and agglutinins are present at 25 hours. They remain in maximum concentration in the blood for 25 hours.


1919 ◽  
Vol 30 (2) ◽  
pp. 123-146 ◽  
Author(s):  
Mildred C. Clough

In this paper are reported the results of a study of nine strains of pneumococci agglutinating with antipneumococcus sera of all three types (Nos. I, II, and III). Seven of the strains were the cause of serious or fatal infections in human beings. Morphologically they were typical pneumococci with characteristic growth on ordinary media. Most of the strains were soluble in bile, fermented inulin, and caused no precipitation on glucose ascitic fluid agar. Two of the strains, however, resembled streptococci in these three cultural characteristics, but have been regarded as pneumococci on account of their serological reactions. Variations in the cultural reactions occurred with several strains while they were under observation. The virulence of the strains varied greatly, some strains being almost non-pathogenic, and others killing mice in doses of 0.000001 cc. of a 24 hour broth culture. Antipneumococcus Sera I, II, and III agglutinated all the strains in fairly high dilution (1:8 to 1:64 or higher), while normal horse serum caused no agglutination. Antipneumococcus Sera I, II, and III stimulated active phagocytosis of all the strains, while no phagocytosis occurred in control preparations with normal horse serum. These strains elaborated a soluble substance in the body of inoculated mice which caused the formation of a precipitate when the peritoneal washings, cleared by centrifugalization, were added to the antipneumococcus sera of all three types. Antipneumococcus Sera I, II, and III protected mice equally well against 1,000 to 10,000 times the minimal lethal dose of the two strains with which protection tests could be carried out. Absorption of serum of Types I and II with the homologous pneumococcus removed the agglutinins and the bacteriotropins for all these strains. Absorption of these sera with Strains T and N removed the agglutinins and the bacteriotropins for the homologous strain only, and not for typical members of Type I or II, or for the other atypically agglutinable strains reported in this paper. The agglutinins concerned in the agglutination of these peculiar strains are therefore minor agglutinins. As shown not only by agglutination tests, but also by protection tests and agglutinin absorption tests, these organisms bear the same relation to Types I, II, and III, as do atypical Type II strains to Type II. Immune sera were prepared with these strains, and each strain was tested with all the immune sera by means of phagocytic and agglutinative reactions. In general, the strains were found to be serologically distinct, though some interrelationships existed between Strains V and R, and between Strains H, F, and N. These sera had no activity towards strains belonging to Type I or II, or atypical Type II. A mutation occurred in one of the strains, B, while it was under observation. On isolation this strain had the cultural reactions of a typical pneumococcus, and had the phagocytic and agglutinative reactions of an atypical Type II. After 6 months cultivation on blood agar its serological reactions changed, and it became actively phagocyted and agglutinated in antipneumococcus sera of Types I, II, and III. Its cultural characteristics also changed, and it became bile-insoluble, did not ferment inulin, and caused precipitation in glucose ascitic fluid agar. At this time it caused an intense green discoloration at the base of the blood agar slants around the water of condensation. By repeated animal passages this strain was three times made to revert abruptly to its original form (atypical Type IIa), both in cultural and serological reactions. An immune serum was prepared to each form of the strain, and each serum acted strongly on the homologous form, but was without action on the heterologous form of the strain. This mutation suggests that these pneumococci reacting with all three types of antipneumococcus sera may represent primitive, relatively undifferentiated forms from which the fixed types may have arisen.


1917 ◽  
Vol 25 (2) ◽  
pp. 211-229 ◽  
Author(s):  
Edgard Zunz ◽  
Charles Mohilevith

Horse serum, kept for 2 hours at 38°C. in the presence of one-fifth its volume of a suspension of 0.5 per cent of pararabin inphysiological salt solution and then freed by means of centrifugalization and filtration from the pararabin produced when injected in appropriate doses into a normal rabbit, a considerable and prolonged fall of the blood pressure, a distinct retardation in the coagulation of the carotid blood, and sometimes, in addition, acceleration of the respiratory rate and the expulsion of numerous scybala; that is, the various symptoms observed to occur after the intravenous injection of horse serum in sero-anaphylactized rabbits. If the horse serum is first heated for 30 minutes to 56°C. and then treated with pararabin in the manner described above, the intravenous injection of this serum into a normal rabbit exerts no more action on the arterial pressure, the coagulability of the arterial blood, the respiratory rate, and the intestinal activity, than does normal horse serum when introduced into the vein of a normal rabbit.


1921 ◽  
Vol 33 (4) ◽  
pp. 471-484 ◽  
Author(s):  
Harry L. Alexander

1. Rabbits which have received a single dose of normal horse serum in the subarachnoid space produce precipitins in the blood in greater abundance, of higher titer, and persisting longer than those in control rabbits which have received a similar injection intravenously. 2. Repeated subarachnoid injections of normal horse serum in rabbits induce precipitins in the blood early. These may appear in high titer as soon as 1 week after the initial injection, whereas in rabbits similarly treated intravenously no precipitins are found at this time. They may appear a few days afterward and reach a high titer. 3. No anaphylactic manifestations occurred in rabbits treated repeatedly with subarachnoid injections of normal horse serum when the precipitin content of the blood was high. 4. Anaphylactins, as determined by passive transfer of anaphylaxis, were demonstrated in sera with high precipitin content. 5. These experiments may explain clinical evidences of anaphylaxis, observed when an initial intravenous injection of horse serum followed a series of intraspinal injections of such serum.


1920 ◽  
Vol 32 (3) ◽  
pp. 283-293 ◽  
Author(s):  
Ida W. Pritchett

1. No demonstrable antiopsonins are formed in rabbits following the intravenous injection of monovalent pneumococcus horse sera, Types I, II, and III. 2. The serum of rabbits injected with immune pneumococcus horse serum, Type I, II, or III, or with normal horse serum, when mixed in the proportion of 1:4 with Type I or Type II pneumococcus horse serum, can greatly augment, in vitro, the opsonization and agglutination of Type I and Type II pneumococci by the homologous immune horse sera. No similar effect is obtained with Type III serum and pneumococci. 3. The increase in opsonization and agglutination is dependent upon (a) specific sensitization of the pneumococci by the homologous immune serum and (b) the presence of the precipitating serum. In the absence of sensitization, as when a heterologous or normal horse serum is employed, opsonization and agglutination do not occur, even though a precipitating mixture is provided. The substitution of normal rabbit serum for the precipitating rabbit serum gives opsonization and agglutination in dilutions slightly higher than are effected with salt solution only, due possibly to the more favorable medium created for the leucocytes by the addition of 25 per cent of whole rabbit serum. 4. Different methods of combining the immune horse serum, precipitating rabbit serum, and pneumococci yield very similar results, preliminary sensitization of the bacteria before precipitation, or precipitation in the rabbit-horse serum mixture before the addition of the pneumococci for sensitization causing little if any difference in result from that obtained when immune horse serum, precipitating rabbit serum, and pneumococci are all mixed and incubated together. 5. This increased opsonization in the test-tube does not seem to be paralleled by increased protective power, or at any rate such protection is not readily demonstrated.


Sign in / Sign up

Export Citation Format

Share Document